Opioid peptides in the cerebrospinal fluid of Alzheimer patients
β Scribed by Michael Muhlbauer; James C. Metcalf Jr.; James T. Robertson; Genevieve Fridland; Dominic M. Desiderio
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 365 KB
- Volume
- 1
- Category
- Article
- ISSN
- 0269-3879
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The cholecystokinin tetrapeptide (CCK-4) and the sulphated octapeptide (CCK-8) were measured in cerebrospinal Β―uid obtained from nine hypothyroid patients before and during L-thyroxine treatment. Before treatment, CCK-4 and CCK-8S correlated negatively with S-TSH, whereas CCK-8S also showed a positi
Acetylcholinesterase (AChE) activity was measured in cerebrospinal fluid (CSF) samples from 36 individuals, including 12 persons with Alzheimer's disease, 12 normal controls, and 12 patients with other dementias. AChE activity also was measured in 47 normal subjects whose ages ranged from 20 to 84 t
Monoamine metabolites, biopterin, acetylcholinesterase (AChE) activity, and somatostatin-like immunoreactivity (SLI) were determined in the lumbar cerebrospinal fluid (CSF) of 24 patients with dementia of the Alzheimer type (DAT) without myoclonus or extrapyramidal signs, in 8 patients with DAT and